Get started
Author

Takumi Sugimoto

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
2009 · Junji Hiraga, Akihiro Tomita, et al. · Blood · 257
PDF
Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
2007 · Akihiro Tomita, Junji Hiraga, et al. · International Journal of Hematology · 56
Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation
2009 · Takumi Sugimoto, Akihiro Tomita, et al. · Biochemical and Biophysical Research Communications · 50
Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis
2016 · Takumi Sugimoto, Takashi Watanabe · Journal of the Japan Society of the Reticuloendothelial System · 48
PDF
Predictors of survival among Japanese patients receiving first‐line chemoimmunotherapy for advanced non‐small cell lung cancer
2020 · Yuri Ogura, Nobutaka Kataoka, et al. · Thoracic Cancer · 33
PDF
Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation—A Case Report and a Review of the Literature
2020 · Izumi Sato, Hiroki Mizuno, et al. · Medicina · 20
PDF
Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
2020 · Nobutaka Kataoka, Yusuke Kunimatsu, et al. · Thoracic Cancer · 6
PDF
Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia
2017 · Yasuhiko Harada, Satoshi Nishiwaki, et al. · Medicine · 6
Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study
2021 · Nozomi Tani, Nobutaka Kataoka, et al. · Multidisciplinary Respiratory Medicine · 5
PDF
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report
2023 · Yurie Seto, Tadaaki Yamada, et al. · Case Reports in Oncology · 4
Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study
2017 · Daisuke Koyama, Satoshi Nishiwaki, et al. · Japanese Journal of Clinical Oncology · 3
[Frequency and prognostic value of chromosome abnormalities in multiple myeloma].
2007 · Shingo Kurahashi, Akiyo Sawamoto, et al. · PubMed · 3
Prediction of Clinical Outcome in Patients with Idiopathic Thrombocytopenic Purpura by Evaluating Bone Marrow Clot CD20+ B Lymphocytes and Morphological Changes of Megakaryocytes
2008 · Fumiko Yamamoto, Hiroto Narimatsu, et al. · Journal of the Japan Society of the Reticuloendothelial System · 2
PDF
A case of adult multisystem Langerhans histiocytosis successfully treated by smoking cessation and radiotherapy for bone lesion
2022 · Chie Yamamoto, Taishi Harada, et al. · Clinical Case Reports · 1
PDF
Discrepancy of CD20 Protein Expression In IHC and FCM Analyses In Primary B-Cell Lymphoma: Relationship Between FCM-Negative Phenotype and Rituximab Binding with Lymphoma Cells
2010 · Takashi Tokunaga, Akihiro Tomita, et al. · Blood · 1
MS4A1 (CD20) Gene Expression Is Down-Regulated by Recruiting the Histone Deacetylase Protein Complex to the Promoter in the CD20-Negative B-Lymphoma Cells After Treatment with Rituximab.
2009 · Takumi Sugimoto, Akihiro Tomita, et al. · Blood · 1
Relationship Between Post-Translational Modification of CD20 Protein and the Responsiveness to Rituximab Treatment
2008 · Takumi Sugimoto, Akihiro Tomita, et al. · Blood · 1
Central Nervous System Relapse after Autologous Peripheral Blood Stem Cell Transplantation in Primary Plasma Cell Leukemia
2006 · Fumiaki Nakamura, Hiroto Narimatsu, et al. · 1
P10-7 Immunological and nutritional predictors for first-line chemoimmunotherapy in advanced non-small cell lung cancer
2021 · Takayuki Takeda, Yuri Ogura, et al. · Annals of Oncology
PDF
P49-9 Atezolizumab in combination with carboplatin and etoposide (CE) for small-cell lung cancer after failure to CE
2021 · Takayuki Takeda, Nobutaka Kataoka, et al. · Annals of Oncology
PDF
CD20 Protein Immunohistochemistry-Positive/Flow Cytometry-Negative Diffuse Large B-Cell Lymphoma—Analyses of the Molecular Mechanisms and Rituximab Effectiveness
2011 · Takashi Tokunaga, Akihiro Tomita, et al. · Blood
CD20-Negative Phenotypic Change In B-Cell Lymphoma Cells After Using Rituximab: Possibility of a Particular Clinicopathologic Phenomenon Post-Rituximab Extranodal CD20-Negative Lymphoma
2010 · Akihiro Tomita, Takashi Tokunaga, et al. · Blood
[Analysis of high-risk multiple myeloma patients treated with high-dose chemotherapy].
2010 · Shingo Kurahashi, Kotaro Suzuki, et al. · PubMed
Difficulty of Peripheral Blood Stem Cell Collection after Multiple Consolidation Therapy in Acute Myeloid Leukemia
2008 · Hiroto Narimatsu, Fumiko Yamamoto, et al. · Journal of the Japan Society of the Reticuloendothelial System
PDF
[Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
2007 · Shingo Kurahashi, Toshihiro Iwasaki, et al. · PubMed
Works count: 27
Citation count: 498
H-index: 6
I10-index: 6
Year
Topic
Type